SIS3 attenuates traumatic heterotopic ossification by targeting TGF-β2-driven endothelial-mesenchymal transition.

Mao D, Lei Z, Guo J, Pan X, Mi J, Rui Y

Open source

DOI
10.1016/j.bcp.2026.118295
Published
2026 Nov
Container
Biochemical pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bcp.2026.118295,
  title = {SIS3 attenuates traumatic heterotopic ossification by targeting TGF-β2-driven endothelial-mesenchymal transition.},
  author = {Mao D and Lei Z and Guo J and Pan X and Mi J and Rui Y},
  year = {2026},
  journal = {Biochemical pharmacology},
  doi = {10.1016/j.bcp.2026.118295},
  url = {https://doi.org/10.1016/j.bcp.2026.118295}
}

RIS

TY  - JOUR
TI  - SIS3 attenuates traumatic heterotopic ossification by targeting TGF-β2-driven endothelial-mesenchymal transition.
AU  - Mao D
AU  - Lei Z
AU  - Guo J
AU  - Pan X
AU  - Mi J
AU  - Rui Y
PY  - 2026
JO  - Biochemical pharmacology
DO  - 10.1016/j.bcp.2026.118295
UR  - https://doi.org/10.1016/j.bcp.2026.118295
ER  - 

APA

D, M., Z, L., J, G., X, P., J, M., & Y, R. (2026). SIS3 attenuates traumatic heterotopic ossification by targeting TGF-β2-driven endothelial-mesenchymal transition.. Biochemical pharmacology. https://doi.org/10.1016/j.bcp.2026.118295

Source records